Media Summary: This Stats, STAT! animated video explores Clinical trials can be stopped early for a range of reasons. But when that happens, it can be tricky to interpret the results and to ... Success in value-based care (VBC) depends on providers working together to deliver high-quality, cost-effective care. However ...

Leveraging Interim Analyses To Optimize - Detailed Analysis & Overview

This Stats, STAT! animated video explores Clinical trials can be stopped early for a range of reasons. But when that happens, it can be tricky to interpret the results and to ... Success in value-based care (VBC) depends on providers working together to deliver high-quality, cost-effective care. However ... From her presentation at IFM's 2025 Annual International Conference (AIC), Kat Toups, MD, IFMCP, shares Enjoy the replay of this invited expert presentation from the 2018 edition of the Cytel Innovations in Clinical Trials Symposium, ... Predicting the length of time needed to reach key enrollment and event milestones is a vital part of planning a clinical trial.

We are pleased to announce an exciting upcoming seminar as part of the ISBS Webinar Series on clinical trial innovation.

Photo Gallery

Leveraging Interim Analyses to Optimize Late Phase Clinical Trial Decision Making
How Interim Analyses Work | NEJM Evidence
Implementing Adaptive Trials
Statistical Review – Early Trial Cessation – When, Why and How to Interpret with Dr. David Harrin...
Jumping  Hurdles: Interim Analyses for Funding Decisions
Optimizing Outcomes: Leveraging Analytics for Provider Performance in Value-Based Care
Reversing Cognitive Decline: A Precision Medicine Randomized Clinical Trial - Interim Analysis
Statistical Considerations for Phase III Randomized Trials, Interim Analysis, and Data Monitoring
Bayesian Optimisation of Enrichment Designs  - Thomas Burnett
Using Interim Data to Improve Expected Study Length
Statistical Considerations for Phase III Randomized Trials, Interim Analysis, and Data Monitoring (中
Is Repeated Bayesian Interim Analysis Consequence-Free?
View Detailed Profile
Leveraging Interim Analyses to Optimize Late Phase Clinical Trial Decision Making

Leveraging Interim Analyses to Optimize Late Phase Clinical Trial Decision Making

Interim analyses

How Interim Analyses Work | NEJM Evidence

How Interim Analyses Work | NEJM Evidence

This Stats, STAT! animated video explores

Implementing Adaptive Trials

Implementing Adaptive Trials

In Episode 11 of "In the

Statistical Review – Early Trial Cessation – When, Why and How to Interpret with Dr. David Harrin...

Statistical Review – Early Trial Cessation – When, Why and How to Interpret with Dr. David Harrin...

Clinical trials can be stopped early for a range of reasons. But when that happens, it can be tricky to interpret the results and to ...

Jumping  Hurdles: Interim Analyses for Funding Decisions

Jumping Hurdles: Interim Analyses for Funding Decisions

In episode 40 of "In the

Optimizing Outcomes: Leveraging Analytics for Provider Performance in Value-Based Care

Optimizing Outcomes: Leveraging Analytics for Provider Performance in Value-Based Care

Success in value-based care (VBC) depends on providers working together to deliver high-quality, cost-effective care. However ...

Reversing Cognitive Decline: A Precision Medicine Randomized Clinical Trial - Interim Analysis

Reversing Cognitive Decline: A Precision Medicine Randomized Clinical Trial - Interim Analysis

From her presentation at IFM's 2025 Annual International Conference (AIC), Kat Toups, MD, IFMCP, shares

Statistical Considerations for Phase III Randomized Trials, Interim Analysis, and Data Monitoring

Statistical Considerations for Phase III Randomized Trials, Interim Analysis, and Data Monitoring

Jack Lee, PhD, DDS.

Bayesian Optimisation of Enrichment Designs  - Thomas Burnett

Bayesian Optimisation of Enrichment Designs - Thomas Burnett

Enjoy the replay of this invited expert presentation from the 2018 edition of the Cytel Innovations in Clinical Trials Symposium, ...

Using Interim Data to Improve Expected Study Length

Using Interim Data to Improve Expected Study Length

Predicting the length of time needed to reach key enrollment and event milestones is a vital part of planning a clinical trial.

Statistical Considerations for Phase III Randomized Trials, Interim Analysis, and Data Monitoring (中

Statistical Considerations for Phase III Randomized Trials, Interim Analysis, and Data Monitoring (中

Jack Lee, PhD, DDS.

Is Repeated Bayesian Interim Analysis Consequence-Free?

Is Repeated Bayesian Interim Analysis Consequence-Free?

We are pleased to announce an exciting upcoming seminar as part of the ISBS Webinar Series on clinical trial innovation.

How Does Interim Analysis Affect Clinical Trial Outcomes? - Trials and Treatments Uncovered

How Does Interim Analysis Affect Clinical Trial Outcomes? - Trials and Treatments Uncovered

How Does